Pharmaceutical Technology

DECEMBER 27, 2022

In a recap of this eventful year, we take a moment to look at some of our biggest stories that relied on data and experts to inform our audience about the latest developments in the world of pharma, medical devices, and clinical trial operations. Tracking the news. Tracking drug development. See you in 2023!

Vaccines 122

Vaccines 122

STAT

JULY 6, 2023

We are quaffing another cup of stimulation – our choice today is gingerbread – are attempting to get organized, a Quixotic notion in our world. On that note, we hope all goes well and that you conquer the world. Nonetheless, we are giving it a go. And of course, do keep in touch… This week, the U.S.

Vaccines 81

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 81

pharmaphorum

NOVEMBER 23, 2020

AZ made the announcemen t as the UK regulator reportedly gears up to make a decision on the rival vaccine from Pfizer and BioNTech, ahead of counterparts in the US and Europe. AZ said the trial has therefore met its main efficacy goal and will immediately prepare filings to regulators around the world to allow early approval.

Vaccines 104

Vaccines 104

Hospital Pharmacy Europe

MAY 2, 2023

Health systems are showing the first major signs of recovery from the Covid-19 pandemic , but further investment in recovery and resilience is needed, according to a new report from the World Health Organization (WHO).

Hospitals 52

Hospitals 52

European Pharmaceutical Review

OCTOBER 24, 2022

The World Health Organization (WHO) COVID-19 Vaccines Global Access (COVAX) reserved one billion doses for distribution to low-income countries. NEWS: GSK to supply Europe with 85mn pandemic flu vaccines… The post Vaccine producers promise equal access in future pandemics appeared first on European Pharmaceutical Review.

Vaccines 67

Vaccines 67

pharmaphorum

AUGUST 16, 2021

The two companies have submitted data from a phase 1 trial in support of the booster dose to the US regulator, and will follow that with filings in Europe and elsewhere in the world in the coming weeks. CureVac, GSK say new-generation jab is much improved.

FDA 104

FDA Vaccines Immunization 104

Pharmaceutical Technology

MAY 16, 2023

The news comes after a tricky opening quarter for Emergent. In February 2022, the FDA accepted Valneva’s vaccine candidate application for priority review after the French biotech company completed a successful Phase III trial in 2022.

Vaccines 52

Vaccines FDA 52

pharmaphorum

DECEMBER 17, 2020

It is the first publicly announced inactivated COVID-19 vaccine candidate to begin clinical development in Europe. But according to Sky News GP practices have been forced to collect data on the rollout of the vaccine shot by hand. This follows problems with the software being used to keep track of who has been given the jab.

Vaccines 104

Vaccines FDA Immunization Hospitals 104

pharmaphorum

DECEMBER 2, 2020

Pfizer and BioNTech are preparing to deliver their COVID-19 vaccine to the UK after the country’s drugs regulator became the first authority in the world to approve it. This welcome news, however, does not mean that we are immediately out of the woods. The NHS stands ready to start vaccinating early next week.

Vaccines 88

Vaccines FDA 88

pharmaphorum

JUNE 18, 2021

Good results for Europe! The court judgment ordering AstraZeneca to deliver to us rapidly 50 million doses is good news for our vaccination campaign. It is also a clear recognition that our Advance Purchase Agreements have a sound legal basis. Our vaccines strategy delivers.

Vaccines 57

Vaccines 57

pharmaphorum

NOVEMBER 12, 2020

In the hours after Pfizer’s momentous vaccine news emerged on Monday #pfizerproud popped up on my social media feeds again and again from the firm’s employees, both past and present. We are a significant step closer to providing people around the world with a much-needed breakthrough to help bring an end to this global health crisis.”.

Vaccines 86

Vaccines FDA 86

European Pharmaceutical Review

JUNE 27, 2023

For World Microbiome Day on 27 June 2023, EPR put questions to Hervé Affagard, CEO and co-founder of MaaT Pharma and Jeffrey Silber, Chief Medical Officer of Vedanta Biosciences, to find out how the field is progressing and what innovations could transform future microbiome-based therapies.

Chemotherapy 101

Chemotherapy Immunization FDA Vaccines 101

pharmaphorum

JANUARY 31, 2022

It is becoming increasingly important for people all over the world to understand the importance of vaccines and to have access to the vaccines they need – especially with digital innovation driving new vaccine development. Innovative new vaccines are being created more rapidly than ever before. About Pfizer.

Vaccines 97

Vaccines Pharmaceutical Companies Pharmaceutical Companies Communication 97

pharmaphorum

OCTOBER 13, 2021

The news sent Swedish firm CombiGene’s shares soaring – almost doubling from SEK6.29 Spark Therapeutics has secured the exclusive rights to CombiGene’s CG01 therapy, which aims to treat drug resistant focal epilepsy, in a deal worth $8.5m in advance with further payments due on reaching clinical milestones. to SEK14.10

57

57

pharmaphorum

FEBRUARY 24, 2021

The company released a statement saying it will meet the EU’s targets by using its global supply chain to make up for any shortfall in Europe, where it is struggling to get production up to speed. The company has not said whether its commitments to the EU will affect supply to other countries around the world.

Vaccines 64

Vaccines Documentation 64

pharmaphorum

JUNE 24, 2022

Although the World Health Organization is still rating the current monkeypox outbreak as a moderate threat , the disease has continued to spread , with 2,103 cases in 42 countries and one confirmed death, according to the latest WHO data. Accordingly, countries around the world are gearing up to address the outbreak.

Vaccines 52

Vaccines Labelling Immunization 52

pharmaphorum

APRIL 29, 2021

Founder and CEO Konstantin Mehl spoke to pharmaphorum’s news editor Richard Staines about why these treatments will be in demand as the world emerges from the pandemic. These account for around 40% of work-related injuries across the company and incidence is high with other employers across the world. About the author.

Insurance 84

Insurance 84

pharmaphorum

JUNE 2, 2021

Capacity to supply Moderna’s COVID-19 vaccine in Europe could be swelled by round 300 million doses a year, following an agreement to set up a new production line at contract manufacturer Lonza. Full approval means it could be used routinely in future as an annual booster, much like the seasonal influenza vaccine.

Vaccines 52

Vaccines Immunization FDA 52

pharmaphorum

DECEMBER 2, 2020

Here we take a look at the colourful history of one of the biggest drugmakers in the world. In 1919 their scientists pioneered mould fermentation production of citric acid from molasses, freeing their citric acid business from European citrus fruit supplies, which had been disrupted by the First World War.

Compounding 127

Compounding Vaccines Pharmaceutical Companies Pharmaceutical Companies 127

pharmaphorum

APRIL 7, 2021

He spoke to pharmaphorum’s news editor Richard Staines to outline his plans to create a European biotech powerhouse. . As the world ponders what is on the other side of the pandemic, van de Winkel is pleased to report that things are much better at Genmab than they were at the end of the last crisis. billion). “It About the author .

Chemotherapy 90

Chemotherapy Hospitals Vaccines 90

pharmaphorum

SEPTEMBER 18, 2020

“Picking the next merger candidate is hard enough, doing so before everyone else jumps on board, then picking the right time to sell makes for a dangerous investment game,” said one BBC News article from December 1998. The deal was instantly controversial in both Europe and the US. Blockbusters go off patent. Pascal Soriot.

Vaccines 113

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 113

The Checkup by Singlecare

FEBRUARY 8, 2024

While the news and popular nutrition chatter have shown a surge in discourse about the dangers of nightshades, “ There are no studies linking nightshades to being detrimental for health,” says Yelena Wheeler , a registered dietitian in Los Angeles, California. Belladonna has also been called “devil’s cherries.”

Compounding 93

Compounding 93

Pharmaceutical Technology

JULY 22, 2022

The World Health Organization (WHO) further stated that at least 18 of the children underwent liver transplants, and one had died. Helen Branswell, an infectious diseases and health reporter at the news website Stat News, shared an article on a monkeypox case being reported in the US, amid rising cases in Spain, Portugal, and Europe.

Vaccines 52

Vaccines Immunization Labelling Hospitals 52

pharmaphorum

FEBRUARY 19, 2021

pharmaphorum’s news editor, Richard Staines, discusses the success stories and failures in R&D that have emerged during the Q4 results period. . Many trials were put on hold during the pandemic, but pharma is under pressure to continue with work on new drugs for other diseases. Parkinson’s woes.

FDA 45

FDA Vaccines 45

Hospital Pharmacy Europe

MARCH 7, 2024

It also demonstrated the widespread use of clopidogrel and linked genetic resistance with a higher risk of recurrent myocardial infarction in this population for the first time, using real-world data. The post Using pharmacogenomics to improve medicines use after myocardial infarction appeared first on Hospital Pharmacy Europe.

Hospitals 52

Hospitals Labelling 52

pharmaphorum

JANUARY 27, 2021

is a phrase I’ve seen repeatedly on social media over the past few weeks, especially when the news broke of the Medicines and Health Products Regulatory Agency’s speedy approval of the Pfizer-BioNTech COVID-19 vaccine in the UK. Suddenly people were comparing the length of approval processes in the UK, Europe, and the US.

Vaccines 52

Vaccines FDA 52

The Guardian - Pharmaceutical Industry

NOVEMBER 26, 2023

Patients’ group says reactions to metamizole can cause sepsis and organ failure – and British and Irish people are at higher risk A patients group representing several British victims has launched legal action against the Spanish government over claims it failed to safeguard people against the potentially fatal side effects of one of the country’s (..)

106

106

Pharma Marketing Network

JUNE 11, 2020

The biggest difference I think is while you were a kind of a sole voice, and you know, starting with news and conference coverage, and then evolving into more opinion pieces about the industry in a bit of a watchdog. So, you continue with Pharma Marketing news. So, from a news perspective, if they can cover that’s wonderful.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Labelling Communication 52

pharmaphorum

APRIL 16, 2021

Taking the longer term view of the last seven years, 2020 was a rather good year for innovative medicine approvals in both the US and Europe – an improvement on 2019, even with the extra approvals of COVID treatments and the first of the vaccines accounted for. The post Three pillars of post-pandemic launch excellence appeared first on.

Pharmaceutical Companies 95

Pharmaceutical Companies Pharmaceutical Companies Documentation Vaccines 95

Hospital Pharmacy Europe

NOVEMBER 29, 2023

We can say, well, look, in this new world of ePMA, if you do it like this you don’t have to go up to the ward in the afternoon when they bleep you for a stock item or a medicine that’s available because you can sit at your desk and do it.

Hospitals 131

Hospitals Community Pharmacies Communication Patient Care 131

ISPE

MAY 10, 2023

Previously, he worked at Aventis and its predecessor companies as Senior Vice President, Industrial Operations, and in many other positions of increasing responsibilities for global supply chain, technology, and manufacturing sites across North America, Europe, and Asia Pacific. Share Your News with 21,000 Members!

Vaccines 52

Vaccines 52

STAT

MARCH 5, 2024

We hope all goes well and you conquer the world. … The White House ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs, its latest effort to draw attention to the program in an election year , STAT writes. and Europe. Continue to STAT+ to read the full story…

Pharmaceutical Companies 93

Pharmaceutical Companies Pharmaceutical Companies 93

The Guardian - Pharmaceutical Industry

OCTOBER 24, 2023

Health regulator says serious side-effects possibly caused by insulin in counterfeit versions of Novo Nordisk’s Ozempic Several people have been admitted to hospital in Austria after using suspected fake versions of Novo Nordisk’s diabetes drug Ozempic, the country’s health safety body has said, the first report of harm to users as a European hunt (..)

Hospitals 51

Hospitals 51

The Guardian - Pharmaceutical Industry

NOVEMBER 2, 2023

Novo Nordisk says it struggling to keep up with demand after becoming Europe’s most valuable company Business live – latest updates The maker of blockbuster weight-loss drug semaglutide has reported a steep rise in sales and profits as health systems around the world rush to use it to tackle obesity.

Pharmaceutical Companies 46

Pharmaceutical Companies Pharmaceutical Companies 46

The Guardian - Pharmaceutical Industry

APRIL 27, 2023

Pascal Soriot says decline in startups across Europe differs markedly from ‘explosion’ of firms and clinical trials in China The boss of Britain’s biggest drugmaker has said that the UK and the rest of Europe are falling behind China and the US in the creation of biotech firms and clinical trials of new medicines.

45

45

The Guardian - Pharmaceutical Industry

JULY 14, 2022

European Commission ‘gave no good reason’ why its president’s messages with Pfizer were not released The EU’s official watchdog has issued a formal reprimand to the European Commission over its president Ursula von der Leyen’s failure to release text messages exchanged with the boss of Pfizer during the pandemic.

52

52

pharmaphorum

JANUARY 26, 2023

In 2018, England was the first country in Europe to provide access to a CAR-T cell therapy to treat these blood cancers, enabled via the Cancer Drugs Fund (CDF). Today’s news is encouraging, as it shows that even in the real-world setting these therapies are living up to their expectations for patients with aggressive forms of lymphoma.”

Chemotherapy 96

Chemotherapy Immunization Hospitals 96